Opportunity ID: 254330

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-14-503
Funding Opportunity Title: Limited Competition for the Data Coordinating Center of Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 25, 2014
Last Updated Date:
Original Closing Date for Applications: Jul 18, 2014
Current Closing Date for Applications: Jul 18, 2014
Archive Date: Aug 18, 2014
Estimated Total Program Funding: $2,500,000
Award Ceiling: $2,500,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Only the current awardee serving as the Data Coordinating Center of Multiethnic Study of Type 2 Diabetes Genes consortium (T2D-GENES) is eligible to apply for this Funding Opportunity Announcement.

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Investigator current awardee of the Accelerating Medicines Partnership (AMP) in Type 2 Diabetes Data Coordinating Center (DCC) (AMP T2D-GENES DCC). The AMP T2D-GENES consortium will consist of the DCC as well as participating sites being solicited by the companion FOA. The mission of AMP T2D-GENES is to characterize the genetic variations in human genomic regions that have been putatively associated with type 2 diabetes (T2D) and conduct follow-up functional studies of particular genetic variants. This is a one-time FOA to provide funds to the AMP T2D-GENES DCC to continue the development of the web portal and deposit, aggregate and process the data generated, as part of an ongoing consortium of AMP T2D-GENES investigators as well as T2D-GENES community, for a maximum of five years, contingent on satisfactory performance. To support the conduct of these studies, AMP T2D-GENES DCC will coordinate manage and support the centers and provide the administrative infrastructure for the NIDDK-funded AMP T2D-GENES consortium. The AMP T2D-GENES DCC will build on and expand the previous work of the T2D GENES consortium.

Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-503.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-C Forms-C PKG00195766 Jun 18, 2014 Jul 18, 2014 View

Package 1

Mandatory forms

254330 RR_SF424_2_0-2.0.pdf

254330 PHS398_ResearchPlan_2_0-2.0.pdf

254330 PHS398_CoverPageSupplement_2_0-2.0.pdf

254330 RR_KeyPersonExpanded_2_0-2.0.pdf

254330 RR_OtherProjectInfo_1_3-1.3.pdf

254330 PerformanceSite_2_0-2.0.pdf

Optional forms

254330 RR_SubawardBudget30_1_3-1.3.pdf

254330 PlannedReport-1.0.pdf

254330 PHS398_CumulativeInclusionReport-1.0.pdf

254330 PHS398_ModularBudget_1_2-1.2.pdf

254330 RR_Budget_1_3-1.3.pdf

2025-07-09T11:38:31-05:00

Share This Post, Choose Your Platform!

About the Author: